New York Life Investment Management LLC Vanda Pharmaceuticals Inc. Transaction History

New York Life Investment Management LLC

  • $9.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
SELL
$3.38 - $4.58 $4,654 - $6,306
-1,377 Reduced 2.63%
51,059 $215,000
Q3 2023

Nov 07, 2023
SELL
$4.28 - $6.57 $35,357 - $54,274
-8,261 Reduced 13.61%
52,436 $226,000
Q2 2023

Aug 04, 2023
SELL
$5.9 - $6.95 $47,011 - $55,377
-7,968 Reduced 11.6%
60,697 $399,000
Q1 2023

May 08, 2023
BUY
$6.18 - $7.99 $424,349 - $548,633
68,665 New
68,665 $466,000

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $247M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email